Health · 1 sources covering this

New HIV treatment options offer some hope amid U.S. funding cuts

The 26th International AIDS conference convenes this week. U.S. funding for HIV/AIDS work is being delayed or cut altogether, but there are also promising treatments on the horizon.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

NPRLean L·2h ago
New HIV treatment options offer some hope amid U.S. funding cuts
The 26th International AIDS conference convenes this week. U.S. funding for HIV/AIDS work is being delayed or cut altogether, but there are also promising treatments on the horizon.
Read at NPR →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/8f575f5276926655b4fde0dd73b274fc32b80ba5"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="New HIV treatment options offer some hope amid U.S. funding cuts"></iframe>

New HIV treatment options offer some hope amid U.S. funding cuts

How 1 sources are covering this

New HIV treatment options offer some hope amid U.S. funding cuts

More from Health

STAT+: Preliminary trial results suggest a path to a safer Alzheimer’s treatment

Cyclospora Boosts Fears That Deadlier Foodborne Outbreaks Are Ahead

Federal Loan Caps Add Barriers — And Likely Debt — for Healthcare Students

Newsom Reverses on Long-Sought Paid Leave Benefit for Teachers in California

Reader

Trust & legal

Across the network

How 1 sources are covering this

New HIV treatment options offer some hope amid U.S. funding cuts

More from Health

STAT+: Preliminary trial results suggest a path to a safer Alzheimer&#8217;s treatment

Cyclospora Boosts Fears That Deadlier Foodborne Outbreaks Are Ahead

Federal Loan Caps Add Barriers — And Likely Debt — for Healthcare Students

Newsom Reverses on Long-Sought Paid Leave Benefit for Teachers in California

Reader

Trust & legal

Across the network

STAT+: Preliminary trial results suggest a path to a safer Alzheimer’s treatment